Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma, Newly Diagnosed”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00075881
What this trial is testing

Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Looking for participantsNCT06158269
What this trial is testing

DVRd in the Treatment of Patients With Newly Diagnosed Double-hit Multiple Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 40
Testing effectiveness (Phase 2)UnknownNCT04935580
What this trial is testing

Study of FasT CAR-T GC012F Injection in High Risk TE NDMM Patients

Who this might be right for
Multiple Myeloma
Shanghai Changzheng Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00089167
What this trial is testing

Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07070934
What this trial is testing

CAR-T vs. Auto-SCT: Which Works Better for New Myeloma Patients?

Who this might be right for
Multiple MyelomaNewly Diagnosed
Xuzhou Medical University 60
Large-scale testing (Phase 3)WithdrawnNCT02155634
What this trial is testing

Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or Thalidomide in Myeloma

Who this might be right for
Multiple MyelomaNeoplasmsPlasma Cells+4 more
Celgene
Large-scale testing (Phase 3)Study completedNCT03901963
What this trial is testing

Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 200
Large-scale testing (Phase 3)Study completedNCT02541383
What this trial is testing

Evaluate Daratumumab in Transplant Eligible Participants With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Intergroupe Francophone du Myelome 1,085
Testing effectiveness (Phase 2)Study completedNCT01217957
What this trial is testing

Ixazomib Administered in Combination With Lenalidomide and Low-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 65
Large-scale testing (Phase 3)Active Not RecruitingNCT03319667
What this trial is testing

Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Who this might be right for
Plasma Cell Myeloma
Sanofi 475
Not applicableStudy completedNCT04248244
What this trial is testing

Effects of Early Palliative Care Integration on Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Case Comprehensive Cancer Center 20
Not applicableNot Yet RecruitingNCT07532473
What this trial is testing

REal World MAIA UK OutcomEs

Who this might be right for
Myeloma
The Royal Wolverhampton Hospitals NHS Trust 300
Testing effectiveness (Phase 2)Study completedNCT02586038
What this trial is testing

STUDY THAT COMPARE 3 ARM: MLN9708 DEXAMETHASONE, MLN9708 CYCLOPHOSPHAMIDE AND DEXAMETHASONE, MLN9708 THALIDOMIDE AND DEXAMETHASONE FOLLOWED BY MAINTENANCE WITH MLN9708 IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTS

Who this might be right for
Multiple Myeloma
Mario Boccadoro 175
Testing effectiveness (Phase 2)Study completedNCT01090921
What this trial is testing

Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Boston VA Research Institute, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT01702831
What this trial is testing

Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance

Who this might be right for
Multiple Myeloma
University Health Network, Toronto 78
Large-scale testing (Phase 3)Study completedNCT00200681
What this trial is testing

IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Nantes University Hospital 493
Testing effectiveness (Phase 2)Active Not RecruitingNCT05849610
What this trial is testing

Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma

Who this might be right for
High-Risk de Novo Multiple Myeloma
PETHEMA Foundation 30
Testing effectiveness (Phase 2)Study completedNCT00477750
What this trial is testing

Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 33
Testing effectiveness (Phase 2)Study completedNCT00724568
What this trial is testing

Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Michigan Rogel Cancer Center 74
Testing effectiveness (Phase 2)Active Not RecruitingNCT04635189
What this trial is testing

Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Rochester 28
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation